TAMOXIFEN THERAPY IN PRIMARY BREAST-CANCER - BIOLOGY, EFFICACY, AND SIDE-EFFECTS

[1] ASHFORD AR, 1988, CANCER, V61, P33, DOI 10.1002/1097-0142(19880101)61:1<33::AID-CNCR2820610107>3.0.CO

[2] 2-I

[3] AUGER MJ, 1988, CANCER, V61, P1316, DOI 10.1002/1097-0142(19880401)61:7<1316::AID-CNCR2820610707>3.0.CO

[4] 2-5

[5] BENRY J, 1987, EUR J CANCE CLIN ONC, V23, P517

[6] BIANCO AR, 1985, REV ENDO REL CANCE S, V17, P123

[7] BRUM LD, 1986, CANCER, V57, P2123

[8] BRUNNERT K, 1985, REV ENDOCRINE RELA S, V17, P99

[9] ESTROGEN USE AND ALL-CAUSE MORTALITY - PRELIMINARY-RESULTS FROM THE LIPID RESEARCH CLINICS PROGRAM FOLLOW-UP-STUDY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (07): : 903 - 906

[10] CAFFIER H, 1985, REV ENDOCRINE RELA S, V17, P103

[1] ASHFORD AR, 1988, CANCER, V61, P33, DOI 10.1002/1097-0142(19880101)61:1<33::AID-CNCR2820610107>3.0.CO

[2] 2-I

[3] AUGER MJ, 1988, CANCER, V61, P1316, DOI 10.1002/1097-0142(19880401)61:7<1316::AID-CNCR2820610707>3.0.CO

[4] 2-5

[5] BENRY J, 1987, EUR J CANCE CLIN ONC, V23, P517

[6] BIANCO AR, 1985, REV ENDO REL CANCE S, V17, P123

[7] BRUM LD, 1986, CANCER, V57, P2123

[8] BRUNNERT K, 1985, REV ENDOCRINE RELA S, V17, P99

[9] ESTROGEN USE AND ALL-CAUSE MORTALITY - PRELIMINARY-RESULTS FROM THE LIPID RESEARCH CLINICS PROGRAM FOLLOW-UP-STUDY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (07): : 903 - 906

[10] CAFFIER H, 1985, REV ENDOCRINE RELA S, V17, P103